P-011: A randomized phase 2 study of modakafusp alfa (TAK-573) in patients (pts) with relapsed/refractory multiple myeloma (RRMM) with a pilot diversity, equity, and inclusion (DEI) strategy

Saved in:
Bibliographic Details
Published inClinical lymphoma, myeloma and leukemia Vol. 22; p. S42
Main Authors Kaufman, Jonathan, Atrash, Shebli, Benson, Don, Holstein, Sarah, Nadeem, Omar, Biran, Noa, Suryanarayan, Kaveri, Liu, Yuyin, Robinson, LaShell, Correa, Karen, Enwemadu, Victoria, Parot, Xavier, Vogl, Dan
Format Journal Article
LanguageEnglish
Published 01.08.2022
Online AccessGet full text

Cover

More Information
ISSN:2152-2650
DOI:10.1016/S2152-2650(22)00341-X